Quarterly report · Q2
3939.TEDINET S100TDG1
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.4bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥3.7bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥669m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥559m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥565m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥684m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥588m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥763m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥406m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥458m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥406m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥5.6bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥5.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥6.5bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.5bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥3.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥438m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥339m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥194m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥842m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥242m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥434m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.3bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥405m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥9.65 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.27 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.08 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.55 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.06 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.58 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥5m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥21m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥613m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥15m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥1.6bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥641m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥285m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥281m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E32603-000Solutions Development Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥2.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥690m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥52,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥52,000 |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥3m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥384m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥384m |
| jpcrp040300-q2r_E32603-000Healthy Lifespan Extension Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥10m |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥52,000 |
| jpcrp040300-q2r_E32603-000Medical And Nursing Care Cloud Platform Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥553m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥52,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥563m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 539
| Item | Context | Value | Unit |
|---|---|---|---|
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社カナミックネットワーク | |
| Filer name in english | FilingDateInstant | Kanamic Network Co.,LTD | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2023-10-01 | |
| Current period end date | FilingDateInstant | 2024-03-31 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2022-10-01 | |
| Comparative period end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2023-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)株式会社ＳＨＯ | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区六本木４丁目３－35 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)山本 拓真 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口） | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)東京都港区赤坂１丁目８－１ | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行（信託口） | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１丁目８－12 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)山本 洋子 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)山本 稔 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都港区 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |